One of the most-asked questions about GLP-2 TZ in 2026 is "can I still buy compounded GLP-2 TZ?" The short answer for therapeutic use is largely no: the FDA officially resolved the GLP-2 TZ shortage in 2024 to 2025, which under FDA Section 503A and 503B compounding rules generally restricts pharmacies from preparing GLP-2 TZ for human use
While all events resolved or were resolving by study end, this highlights the importance of monitoring volume status when using SZC in advanced HF [82]
During a 48-week phase 2 obesity trial, patients on weekly doses of Retatrutide (8 mg and 12 mg) had average body weight losses of 22.8% and 24.2%, respectively
Tirzepatide tends to produce greater weight reduction, while semaglutide often costs less and works well for many patients
Recommended Reconstitution Solvents Sterile bacteriostatic water (0.9% benzyl alcohol) is the most widely used solvent for research peptide reconstitution, offering extended post-reconstitution stability when stored at -20C
In three trials, one- or two-step dose increases up to the 20 g OD treatment dose were compared [13, 17, 18], and in one trial, morning and evening dosing of lixisenatide were compared [19]